Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
European Lung Cancer Working Party
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histological or cytological diagnosis of non-small cell carcinoma of the lung
Initially stage III NSCLC
Pathologically proven N2 or N3 disease
Any response to induction chemotherapy (whatever the regimen administered)
Disease still not fully resectable (because of extensive mediastinal N disease) and not suitable for radical radiotherapy (single field) after induction chemotherapy
Lobectomy possible for the treatment of T disease
Availability for participating in the detailed follow-up of the protocol
Informed consent
You may not be if
Prior treatment with radiotherapy or surgery
Karnofsky PS \< 60
Functional or anatomical contra-indication to mediastinal radiotherapy
Functional or anatomical contra-indication to surgical lobectomy
A history of prior malignant tumour, except non-melanoma skin cancer or in situ carcinoma of the cervix or cured malignant tumour (more than 5 year disease-free interval)
